crime
1 min read
Luigi Mangione Pleads Guilty to Federal Stalking Charges in CEO's Death
Luigi Mangione pleaded guilty to federal stalking charges, confessing to the shooting of UnitedHealthcare CEO Brian Thompson. This plea occurred in a federal court in New York.
08/23/2026 · Cottonwood County edition
Advertisement
Advertisement
Why it matters locally: The victim, Brian Thompson, was the CEO of UnitedHealthcare, a company headquartered in Minnetonka, Minnesota. This development in the federal case has implications for a major Minnesota-based employer and its leadership.
NEW YORK — Luigi Mangione pleaded guilty to federal stalking charges on Wednesday, admitting to the shooting death of UnitedHealthcare CEO Brian Thompson. Mangione made his admission in a federal court in New York. During the hearing, Mangione confirmed his responsibility for Thompson's death. Authorities apprehended Mangione in October 2023 in Selinsgrove, Pennsylvania, after a nationwide manhunt. The arrest followed the shooting of Thompson on December 2, 2020, outside a hotel in New York City. Federal prosecutors stated Mangione tracked Thompson for months before the shooting. Court documents indicated Mangione used encrypted messaging applications and virtual private networks to conceal his activities. He reportedly harbored grievances against UnitedHealthcare stemming from a dispute over disability benefits for his ex-wife. Investigators found a manifesto and additional writings from Mangione outlining his intent to harm insurance executives. The federal plea resolves the federal charges against him. Mangione still faces separate murder charges in New York state court related to Thompson's death.Related Topics
Editorial Transparency
AI-Generated · Written by National DeskArticle Ratings
Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0
How do you feel about this story?
NA
National Desk
Trust 3.1104108 articles8,220,515 views75% fact accuracy
View ProfileSign in to follow this author from their profile.

Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!